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Abstract
Background: Mesendoderm induction during embryonic stem cell (ESC) differentiation in vitro is stimulated by the
Transforming Growth Factor and Wingless (Wnt) families of growth factors.
Principal Findings: We identified the periods during which Bone Morphogenetic Protein (BMP) 4, Wnt3a or Activin A were
able to induce expression of the mesendoderm marker, Mixl1, in differentiating mouse ESCs. BMP4 and Wnt3a were
required between differentiation day (d) 1.5 and 3 to most effectively induce Mixl1, whilst Activin A induced Mixl1
expression in ESC when added between d2 and d4, indicating a subtle difference in the requirement for Activin receptor
signalling in this process. Stimulation of ESCs with these factors at earlier or later times resulted in little Mixl1 induction,
suggesting that the differentiating ESCs passed through ‘temporal windows’ in which they sequentially gained and lost
competence to respond to each growth factor. Inhibition of either Activin or Wnt signalling blocked Mixl1 induction by any
of the three mesendoderm-inducing factors. Mixing experiments in which chimeric EBs were formed between growth
factor-treated and untreated ESCs revealed that BMP, Activin and Wnt signalling all contributed to the propagation of
paracrine mesendoderm inducing signals between adjacent cells. Finally, we demonstrated that the differentiating cells
passed through ‘exit gates’ after which point they were no longer dependent on signalling from inducing molecules for
Mixl1 expression.
Conclusions: These studies suggest that differentiating ESCs are directed by an interconnected network of growth factors
similar to those present in early embryos and that the timing of growth factor activity is critical for mesendoderm induction.
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Introduction
The in vitro differentiation of embryonic stem cells (ESCs)
represents an accessible system for analyzing parameters influenc-
ing the early stages of lineage specification and commitment.
During differentiation, ESCs pass through a series of develop-
mental milestones that mirror those traversed by cells within the
embryo [1–3]. For example, gene-profiling experiments indicate
that differentiating mouse ESCs sequentially express genes
marking successive stages of embryonic development, including
Oct4 and Sox2 (inner cell mass), Fgf5 (epiblast) and Brachyury, Mixl1
and Gsc (primitive streak) [2]. Following the expression of these
genes, induction of markers representing differentiated cell types
can be observed, such as Pdx1 (foregut endoderm), Nkx2-5 (cardiac
mesoderm) and bH1 globin (yolk sac erythroid cells) [2]. Thus,
parallels exist between the differentiation pathways used by ESCs
in vitro and the developmental roadmap followed by cells during
the early stages of embryogenesis [4].
Not only is there a correspondence between the developmental
pathways followed by cells in vitro and in vivo, but there is a
similar concordance between the factors that induce and pattern
ESCs and the embryo during differentiation. For example,
induction of the primitive streak, the structural harbinger of
mesendoderm formation in the embryo, requires the activity of a
number of secreted growth factors (reviewed in [5]). Specifically,
embryos lacking BMP4, Wnt3, nodal or their receptors, display
gastrulation and mesendoderm patterning defects [6–14]. Simi-
larly, in vitro studies on ESCs indicate that stimulation by these
ligands initiates mesendoderm formation, as evidenced by the
expression of primitive streak markers Brachyury, Mixl1 and
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Wnt and Activin (nodal) signalling is absolutely required for this
process, indicating that fundamental parallels exist between the
differentiation of early embryonic cell types in vitro and in vivo
[16,18–20].
In this study we determined the periods within which BMP4,
Wnt3a and Activin A induced mesendoderm in differentiating
mouse ESCs. These factors acted during discrete ‘temporal
windows’ to induce expression of a GFP reporter gene targeted
to the locus of the primitive streak gene, Mixl1. We demonstrated
that endogenously produced factors propagated paracrine mesen-
dodermal inducing signals through embryoid bodies (EBs). Finally,
we observed that the differentiating cells passed through ‘exit
gates’ after which point they were no longer dependent on
signalling from inducing molecules for Mixl1 expression. Overall,
our study suggests that growth factor regulatory loops similar to
those present in early embryos also exist within EBs. The timing of
growth factor activity is critical for the initiation of mesendoderm
formation from ESCs and paracrine signalling contributes to
mesendoderm development.
Results
Maximal mesendoderm inducing activity of BMP4,
Activin A and Wnt3a occurs within discrete temporal
windows
We utilised a genetically modified mESC line, Mixl1
GFP/w [17],
in which sequences encoding GFP were inserted into one allele of
Mixl1, a gene whose expression is restricted to the mesendodermal
precursors of the primitive streak [21,22]. GFP acts as a surrogate
marker for expression of Mixl1, and indicates the emergence of
nascent mesoderm and endoderm from differentiating ESCs.
In order to identify the period during differentiation when cells
were responsive to mesendoderm inducing growth factors.
Mixl1
GFP/w ESCs were differentiated in a chemically defined
medium (CDM) [23] supplemented with BMP4 for 24 h, with the
time of initial addition to the culture staggered at daily intervals
from d0 to d4 (Figure 1A). At the end of each 24 h period, the
BMP4-supplemented medium was removed and the EBs left to
differentiate further in fresh medium without growth factor. The
cells were analysed for GFP expression by flow cytometry at d5,
since the highest percentage of GFP
+ cells were observed on this
day, and expression rapidly waned thereafter. This was consistent
with observations that GFP maturation and fluorescence lagged
behind the peak of Mixl1 mRNA expression that was maximal at
d4 of differentiation [17,24]. These experiments revealed that
BMP4 most effectively induced expression of GFP from the Mixl1
locus (denoted Mixl1GFP) when present in the cultures from d1–2
(63.262.6%; mean6sd of GFP
+ cells from 3 independent
experiments) and d2–3 (44.269.6%) (Figure 1B). Experiments in
which the timing of BMP4 addition was offset by 12 h (Figure 1A)
indicated that peak induction of Mixl1GFP
+ cells was observed
when BMP4 was added from d1.5–2.5 (55.864.6%). A lower
frequency of GFP
+ cells was seen in d5 cultures stimulated
between d2.5 and d3.5 (21.267.4%) (Figure 1B). Finally, very few
Mixl1GFP
+ cells were induced by stimulating the cells from d0.5–
1.5 or from d3–4. Combining these data sets suggested that cells
would be maximally responsive to BMP4 between d1.5 and d3 of
differentiation. This prediction was confirmed in the experiment
shown in Figure 2A, in which over 85% of the cumulative total of
GFP
+ cells was observed in cultures stimulated with BMP4
between d1.5 and d3.
A similar series of 24 h pulse experiments conducted with
Wnt3a and Activin A as the differentiation stimuli defined the
Figure 1. Mesendoderm inducing activity of BMP4 is restricted to a specific temporal window during ESC differentiation. (A) Flow
cytometric analysis of d5 Mixl1
GFP/w ESCs differentiated in cultures supplemented with 10 ng/ml BMP4 for 24 h with the time of initial growth factor
addition to the culture staggered at daily intervals starting at d0 (upper panels) or day 0.5 (lower panels). The proportion of GFP
+ cells in this
experiment is shown in the lower right of each plot. Flow cytometry profiles from no growth factor (-GF) control cultures are shown to the left of each
series. (B) Histograms summarising flow cytometry data from three independent experiments, showing the average percentage of GFP
+ cells at d5
observed for each period of BMP4 addition. (mean6sd, n=3).
doi:10.1371/journal.pone.0010706.g001
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and that for Activin A to be between d2 and d4 (data not shown).
On the basis of these preliminary studies, further differentiation
experiments were performed in which the growth factors were
included prior to, during and after the hypothesized optimal Mixl1
induction window for each growth factor. These experiments
confirmed that BMP4 and Wnt3a were most effective at inducing
GFP
+ mesendoderm precursors when present in the cultures
between d1.5 and d3 (Figure 2A, B). In contrast, Activin A most
efficiently induced GFP expression when present between d2 and
d4 of differentiation (Figure 2A, B). The inclusion of each growth
factor during its optimal window of action also increased the size
and viability of the EBs compared to EBs cultured in CDM
without growth factors (Figure 2C and data not shown). The larger
EB size suggests that the growth factors probably influenced cell
survival and proliferation as well as differentiation. Indeed, we
have previously shown that supplementation of serum free
medium with BMP4 augmented the total cell number and viability
of differentiating mouse ESCs, and that this effect was observed
prior to the induction of GFP in Mixl1
GFP/w ES cells [17]. We
have argued that this may correspond to the growth-promoting
effect of BMP4 on epiblast cells prior to gastrulation [6,11,12].
Similar outcomes in experiments performed with an indepen-
dently targeted Mixl1
GFP/w reporter ESC line, (clone Mix 114)
[17], indicated that the temporal windows delineated in this study
for each growth factor were not specific for a single ESC line
(Figure S1). Nevertheless, because the two Mixl1
GFP/w clones were
derived from the same parental ESC line, we cannot rule out the
possibility that different strains of ESCs might vary in their
propensity to differentiate. However, in our experience, ESC lines
generally respond to growth factors in a similar manner, with the
main differences being in the concentration of factors required for
the development of specific cell types (Elizabeth Ng, EGS and
AGE, unpublished results).
Even in our relatively well defined, short-term differentiation
experiments, we observed that, at best, 60–70% of cells expressed
GFP from the Mixl1 locus, and that the variable fluorescence
intensity observed indicated that not all Mixl1GFP expressing cells
were identical. Interestingly, we have previously observed that this
heterogeneity for Mixl1GFP expression is more evident within
individual EBs than between EBs [17]. In other words, most EBs
express Mixl1GFP but not all cells in each EB express GFP.
Interdependence of signalling pathways in
mesendoderm induction
We sought to determine whether all three growth factor
signalling pathways were required for GFP induction in differen-
tiating Mixl1
GFP/w cells. In the first instance, we examined the
effects of adding inhibitors for Wnt and TGF-beta pathways on
the ability of each ligand to induce MixlGFP expressing cells.
ESCs were treated with BMP4 or Wnt3a from d1 or with Activin
A from d2, because preliminary experiments showed that addition
of this factor prior to d2 inhibited ESC mesendoderm differen-
tiation (data not shown). Inhibitors of BMP4- (noggin), Activin
receptor- (SB 431542) or canonical Wnt- (Dkk-1) signalling were
added to the cultures at the same time as the growth factors.
Cultures were analysed at differentiation d5 for expression of GFP
by flow cytometry.
As anticipated, addition of a compound that inhibited the
signalling pathway of the inducing agent completely ablated
subsequent GFP-expression (Figure 3A). However, the Activin
signalling inhibitor SB 431542 blocked GFP induction by all of the
growth factors, underlining the pivotal role nodal signalling plays
in mesendoderm formation [16,18]. Somewhat unexpectedly,
addition of noggin to Wnt3a treated cultures consistently
suppressed induction of GFP-expressing cells by about 50%
(Figure 3A, B), suggesting that endogenously produced BMP
activity synergised with the exogenously added Wnt3a. In contrast,
noggin had no impact on the frequency of GFP
+ cells observed in
d5 cultures which had been treated with Activin A (Figure 3A, B).
The addition of Dkk-1 substantially reduced but did not eliminate
subsequent induction of GFP
+ cells in BMP4 treated cultures, and,
in agreement with the results of others, Mixl1 induction was
obviated by Dkk-1 treatment of Activin A induced cultures
(Figure 3A, B) [16].
In order to investigate the ligands endogenously produced by
differentiating ESCs, PCR analysis was performed on cDNA
synthesized from d3 EBs differentiated in the presence of either
BMP4, Wnt3a or Activin A. This survey focused on genes
encoding factors that previous gene profiling experiments had
shown were expressed during ES differentiation [2]. BMP4
induced expression of Wnt3, Wnt8a and nodal, factors that may
have contributed to endogenously produced signals inhibited by
Dkk-1 or SB 431542 (Figure 3C). Likewise, d3 cells that had been
treated with Wnt3a produced transcripts representing BMP4,
Wnt3, Wnt8a and nodal (Figure 3C). The presence of BMP4
transcripts in these samples may explain the suppressive effect of
noggin on the frequency of Mixl1GFP
+ cells induced by Wnt3a
(Figure 3A, B). A similar analysis performed on d3 samples of
Activin A treated cells revealed low levels of transcripts
representing Wnt3, Wnt8a and nodal.
Real time PCR analysis confirmed the observation that both
BMP4 and Wnt3a were able to induce substantial expression of
BMP4, Wnt3 and nodal. Activin A, only present for 24 hours at this
time point, predominantly promoted the up regulation of Wnt3
and nodal, with BMP4 expression retained at similar levels to those
observed in unstimulated cells (Figure 3D).
Endogenously produced growth factors provide
paracrine mesendoderm inducing signals in
differentiating embryoid bodies
These results implied that endogenously produced BMP, Wnt
and Activin-like molecules might play an important role during
mesendoderm induction during ESC differentiation in vitro by
complementing the actions of exogenously applied growth factors.
To directly assay the paracrine mesendoderm inducing ability of
these endogenous factors, we performed mixing experiments in
which wild type Mixl1
w/w ESCs differentiated for 3d in the
Figure 2. Mesendoderm inducing activities of BMP4, Wnt3a and Activin A are restricted to specific temporal windows during ESC
differentiation. (A) Flow cytometry analysis at d5 of a representative experiment of Mixl1
GFP/w ESCs differentiated in cultures supplemented with
10 ng/ml BMP4, 100 ng/ml Wnt3a or 100 ng/ml Activin A for the indicated time intervals (measured in days after initiation of differentiation). The
proportion of GFP
+ cells is shown in the lower right of each plot. The flow cytometry profiles from no growth factor (-GF) control cultures are shown
to the left of each series. (B) Histogram summarising flow cytometry data measuring the proportion of GFP
+ cells at d5 in EBs treated with Wnt3a or
Activin A during the time intervals indicated (days) (mean6sd, n=3). (C) Brightfield and epifluorescence images of differentiating EBs. The growth
factors and period of addition are indicated to the left of each row and day of differentiation when the image was taken in the top right hand corner
of each panel. (Original magnification6100).
doi:10.1371/journal.pone.0010706.g002
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Mixl1
GFP/w cells that were derived from EBs differentiated for 3d
in the absence of exogenous factors, to form chimeric EBs
(Figure 4A). These chimeric spin EBs were left to differentiate for a
further 2d in the absence of exogenous growth factors. We
hypothesized that the wild type ‘stimulator’ EBs would differen-
tiate towards mesendoderm in response to the growth factors
during the first 3d but that the Mixl1
GFP/w ‘responder’ EBs,
cultured in the absence of stimulation, would not. Following the
final 2d of differentiation as chimeric EBs, any mesendoderm
inducing signal produced by the ‘stimulator’ cells transferred to the
‘responder’ Mixl1
GFP/w cells would be read out as an induction of
GFP
+ cells by flow cytometry at d5. We chose the period of growth
factor stimulation to include at least part of the optimal windows of
response to BMP4, Wnt3a and Activin A. Furthermore, based on
our earlier results, we argued that the period of chimeric EB
differentiation (d3–d5) fell outside the window of optimal
responsiveness of the EBs to direct BMP4 or Wnt3a induction of
Mixl1GFP
+ cells.
Analysis of Mixl1GFP expression in the chimeric EBs showed
that, in the absence of exogenously added growth factors to the
‘stimulator’ cultures, no GFP
+ cells were observed in the chimeric
EBs at d5 (Figure 4B, C). Conversely, wild type Mixl1
w/w ESCs
differentiated for 3d in the presence of BMP4 or Wnt3a produced
a mesendoderm-inducing signal that stimulated the ‘responder’
Mixl1
GFP/w cells to induce GFP (Figure 4B, C). On average,
10.264.6% and 10.267.2% Mixl1GFP
+ cells were observed in d5
chimeric EBs that included wild type cells stimulated from d0–d3
by BMP4 and Wnt3a respectively. Given that only ,50% of the
cells in each chimeric EB were ‘responder’ Mixl1
GFP/w cells, these
data argue that ,20% of these cells upregulated Mixl1 and
expressed GFP in response to the co-cultivation with growth factor
stimulated wild type ESCs. However, Activin A treated ‘stimula-
tor’ wild type ESCs were not able to induce GFP expression in
‘responder’ Mixl1
GFP/w cells (Figure 4B, C), perhaps reflecting the
relatively low levels of growth factor gene expression observed in
d3 EBs that had been stimulated with Activin A for only 24 hours
(Figure 3C, D).
Figure 3. Induction of maximal proportions of GFP
+ Mixl1
GFP/w cells requires signalling via BMP, Wnt and Activin receptor pathways.
(A) Flow cytometry analysis at d5 of a representative experiment of Mixl1
GFP/w ESCs differentiated in cultures supplemented with BMP4 (d1–d5),
Wnt3a (d1–d5) or Activin A (d2–d5) alone or in the presence of the signalling pathway inhibitors noggin, Dkk-1 or SB 431542. Growth factors are
shown to the left of each row and inhibitors are shown at the top of each column. Flow cytometry profiles obtained from control cells with no growth
factor added (-GF) are shown in the bottom left panel. The percentage of GFP
+ positive cells is recorded in the bottom right corner of each plot. (B)
Histogram summarising flow cytometry data measuring the proportion of GFP
+ cells at d5 in EBs treated with BMP4, Wnt3a or Activin A with and
without inhibitors. (mean6sd, n=3)( *p ,0.05, ** p,0.01 compared to cells not receiving inhibitor). SB; SB 431542. (C) Semi-quantitative RT-PCR
analysis of growth factor gene expression in cells from d3 cultures stimulated with BMP4 (d1–d3), Wnt3a (d1–d3) or Activin A (d2–d3). The samples
are indicated at the top of each column and the growth factor genes analysed on the left of each row. ESC; undifferentiated ESCs, -GF; no growth
factor, Act A; Activin A, H2O; no template control. (D) Real time PCR analysis of BMP4, Wnt3 and nodal gene expression at d3 in ESCs differentiated in
the presence of BMP4 (d1.5–d3), Wnt3a (d1.5–d3) and Activin A (d2–d3). (mean6sem, n=3). (* p,0.05, ** p,0.01 compared to samples collected
from cells differentiated in the absence of growth factor.)
doi:10.1371/journal.pone.0010706.g003
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signaling pathways in the transfer of mesendoderm inducing
signals, the effects of adding inhibitors of these pathways at the
time of chimeric EB re-aggregation (at d3) was assessed. In the
absence of inhibitors, wild type ‘stimulator’ ESCs treated with
BMP4 or Wnt3a between d1–d3 effectively induced GFP
expression in ‘responder’ Mixl1
GFP/w cells (Figure 4D). Inclusion
of Dkk-1 or SB 431542 completely abrogated transfer of the
mesendoderm-inducing signal from the growth factor treated
‘stimulator’ cells to the Mixl1
GFP/w ‘responder’ ESCs, indicating
that signaling via these pathways was absolutely required
(Figure 4D). In addition, noggin treatment of the chimeric EBs
also diminished the frequency of GFP
+ cells seen in the ‘responder’
Mixl1
GFP/w ESCs (Figure 4D). This argued that BMP signalling
still played a role in paracrine stimulation of mesendoderm
formation, even though, by itself, BMP4 was a poor inducer of
mesendoderm after d3. The failure of noggin to completely
abrogate the induction of GFP expression confirmed that factors
in addition to BMP4 mediated the paracrine signal transfer
(compare Figure 4D with Figure 3A).
BMP, Wnt and Activin signaling are required after d3 to
maintain mesendoderm gene expression
Results of studies presented thus far suggested that the window
during which BMP4 and Wnt3a efficiently induced GFP
expression in Mixl1
GFP/w cells closed soon after d3, consistent
with the observation that addition of these growth factors after this
time did not recruit many new cells into the mesendoderm
differentiation program. However, this scenario did not exclude an
ongoing requirement for active signaling past d3 for maximal GFP
induction and/or maintenance in cells that had already committed
to mesendoderm formation, a possibility raised by the effects of
signaling pathway inhibitors on paracrine mesendoderm signals
shown in Figure 4.
Therefore, experiments were performed to examine the
requirement for BMP, Wnt and Activin signaling after an initial
period of mesendoderm induction by each growth factor.
Mixl1
GFP/w cells were differentiated until d3 in the presence of
BMP4 or Wnt3a (both added at d1) or Activin A (added d2). At
d3, the factors were removed and cells differentiated for a further
two days in the presence or absence of inhibitors affecting each
pathway (Figure 5A). Gene expression analysis indicated that by
d3, cells treated with BMP4 and Wnt3a had up-regulated
expression of the pan-mesendodermal markers, Brachyury and
Mixl1, the anterior mesendodermal genes Goosecoid and FoxA2 and
the visceral and definitive endodermal marker Sox17 (Figure 5C
and real time PCR data shown in Figure S2). In the case of Mixl1,
this expression at d3 translated into a substantial fraction of GFP
+
cells by d5 (Figure 5A, B). However, much lower levels of Mixl1
and Brachyury were expressed by d3 in response to Activin A, which
was only present in these experiments for 24 h (Figure 5C and
Figure 4. ES Cells differentiated in response to BMP4 or Wnt3a
generate paracrine signals that induce GFP in Mixl1
GFP/w EBs.
(A) Method used to assess the ability of ‘stimulator’ wild type Mixl1
w/w
ESCs differentiated in the presence of growth factors to induce
expression of GFP in ‘responder’ Mixl1
GFP/w ESCs differentiated in
absence of exogenous growth factors. After 3d of differentiation, both
‘stimulator’ and ‘responder’ EBs were disaggregated and chimeric spin
EBs formed by re-aggregating ‘stimulator’ and ‘responder’ cells in a 1:1
ratio. After allowing differentiation to proceed for a further 2d in the
absence of growth factors the chimeric EBs were harvested for analysis.
(B) Flow cytometry analysis of d5 chimeric EBs. The growth factors used
for the ‘stimulator’ and ‘responder’ cultures for the initial 3d of
differentiation are shown above each panel of a representative
experiment (stimulator/responder). All ‘responder’ differentiations were
performed in the absence of added growth factors (/-GF). The flow
cytometry profiles obtained using ‘stimulator’ cells not exposed to
growth factor (-GF/-GF) are shown as a negative control. The
percentage of GFP
+ cells is shown. (C) Histogram summarising the
flow cytometry data at d5 (mean 6sd, n=3). (D) Flow cytometry
analysis of d5 chimeric EBs formed by aggregating growth factor
stimulated wild type Mixl1
w/w with unstimulated Mixl1
GFP/w differenti-
ating ESCs at d3. At the time of aggregation, inhibitors of BMP (noggin),
canonical Wnt (Dkk-1) and Activin receptor (SB 431542) signalling were
added to the cultures. Growth factors used to stimulate the wild type
ESCs from d0–d3 are shown to the left of each row. Inhibitors are shown
at the top of each column. Flow cytometry profiles obtained with cells
from the no growth factor (-GF) control cultures are shown. The
percentage of GFP
+ positive cells is recorded in the bottom right corner
of each plot. SB; SB 431542.
doi:10.1371/journal.pone.0010706.g004
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in only ,10% of cells by d5, a proportion that represents only
,30% of the d5 expression observed when Activin was included
from d2–d4.
In all cases, inclusion of either noggin, Dkk-1 or SB 431542 at
d3 reduced the proportion of GFP
+ cells at d5 to varying degrees,
suggesting that ongoing signaling through all of the pathways was
required for maximal mesendoderm formation in response to each
inducing growth factor. However, differences were observed in the
patterns of GFP expression that largely depended upon the
inhibitor that was used. In cells stimulated for 3d by BMP4,
inclusion of noggin at d3 reduced the frequency of GFP
+ cells by
,20% (from 67.862.0% to 52.765.9%) whilst Dkk-1 and SB
431542 reduced the proportion of GFP expressing cells by ,70%
(from 67.862.0% to 22.366.9%) and ,80% (from 67.862.0% to
11.762.3%) respectively (Fig. 5B). Similarly, in the case of cells
stimulated by Wnt 3a or Activin A, the greatest reduction in the
fraction of GFP
+ cells was seen following addition of Dkk-1 and SB
431542 (,75% and ,90% respectively), whilst a lesser reduction
in the proportion of GFP
+ cells was observed in response to
treatment of cells at d3 with noggin (,35%) (Figure 5B).
Interestingly, for cells stimulated by either BMP4 or Wnt3a,
inclusion of the SB 431542 inhibitor at d3 only partially inhibited
the appearance of GFP
+ cells at d5 compared with results obtained
when the inhibitor was included from the onset of the
differentiation, which completely suppressed induction of
Mixl1GFP
+ cells (see Figure 3B). This indicated that a proportion
of d5 Mixl1GFP
+ cells were committed to mesendoderm
formation by d3 and no longer dependent upon nodal signaling
during the last 2 days of differentiation.
Examination of gene expression at d5 demonstrated that Mixl1
RNA had begun to wane in cells stimulated by BMP4 or Wnt3a
(Figure 5D). Conversely, d5 Mixl1 expression was increased over
d3 levels in Activin A stimulated cultures, illustrating differences in
the kinetics of Mixl1 induction. Brachyury, Goosecoid, FoxA2 and
Sox17 were also expressed at higher levels in d5 Activin A
stimulated samples. In all these cases, including the inhibitor SB
431542 significantly reduced gene expression, confirming that
induction was dependent upon Activin A/nodal signaling. These
trends in gene expression induced in response to BMP4, Wnt3a
and Activin A stimulation were confirmed in an independent series
of experiments (Figure S2).
The observation that Dkk-1 addition at d3 prevented the
emergence of GFP
+ cells in EBs stimulated with Activin A,
suggested that endogenously produced Wnt ligands were necessary
for Activin A to recruit cells to mesendoderm formation, even after
the window for optimal Wnt3a induction of Mixl1 expression
appeared to have passed. A corollary of this hypothesis would be
that Wnt3a might synergise with Activin A in the induction of
mesendoderm after d3. To test this hypothesis, we analysed the
induction of Mixl1 in response to combinations of growth factors
added to cells at d3. Consistent with our earlier results, these
Figure 5. BMP4, Wnt and Activin signalling are required after d3 for maximal GFP induction from Mixl1
GFP/w EBs. (A) Flow cytometry
analysis of GFP expression in d5 Mixl1
GFP/w EBs stimulated with BMP4 (d1–3), Wnt3a (d1–3) or Activin A (d2–3) and subsequently treated from d3–5
with the inhibitors noggin, Dkk-1 or SB 431542. SB; SB 431542. (B) Histogram summarising d5 flow cytometry data (mean6sd, n=3)( *p ,0.05,
** p,0.01 compared to cells not receiving inhibitor). SB; SB 431542. (C, D) Gene expression analysis of (C) d3 and (D) d5 differentiating mESCs treated
with exogenous BMP4, Wnt3a and Activin A. The growth factor and treatment days are indicated across the top of each sample. Samples to which the
Activin signalling inhibitor SB 431542 was added are indicated (SB), as are control samples that were treated with DMSO carrier (DM). The genes
analysed are shown on the left hand side of each row.
doi:10.1371/journal.pone.0010706.g005
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of GFP expression at d3, but that treatment of d3 cells with Activin
A resulted in ,30% GFP expressing cells at d5 (Figure 6A, B).
Furthermore, there was no evidence for synergy between BMP4
and Wnt3a or BMP4 and Activin A added at d3 since the
frequency of GFP
+ cells was no higher than that observed by
treating the cells with the single factors. However, addition of
Wnt3a together with Activin A consistently resulted in a higher
proportion of GFP
+ cells (42.664.7%) than that seen with either
ligand alone (2.060.7% for Wnt3a and 29.666.3% for Activin A)
and higher than that predicted by addition of contributions
representing the individual factors (Figure 6A, B). The inclusion of
all three factors did not further increase the percentage of GFP
expressing cells. These results suggest a second function for Wnt
signaling as a necessary but not sufficient component in the late
induction or maintenance of GFP
+ mesendoderm distinct from its
role as a direct inducer of early mesendoderm formation.
Discussion
Before discussing the specific findings of this study in detail, it is
valuable to place our results into a historical context, by relating
our work to earlier studies that identified the nexus between ESCs
and germ cell tumours. Benign germ cell tumours (teratomas)
comprise mixtures of many different adult tissue types, whilst their
malignant counterparts (teratocarcinomas) also include persistent
undifferentiated stem cell components, termed embryonal carci-
noma cells (ECCs) [25]. A number of excellent reviews over the
years have covered this topic and the reader is referred to these for
more complete descriptions of the research [25–28]. The concept
that the multiple differentiated cell lineages found in teratomas
might be derived from a single cell type was proposed over 100
years ago [29]. However, it was not until the 1950s, when Stevens
and Little observed that inbred strain 129 mice developed
spontaneous testicular teratomas, that there was an opportunity
to systematically study these interesting tumours [30]. Stevens
noted that teratocarcinomas maintained as an ascites tumour
formed ‘‘thousands of free floating embryoid bodies similar to
mouse embryos 5 and 6 days of age in the peritoneal fluid.’’ [31].
In a technical tour de force, Kleinsmith and Pierce dissociated
small embryoid bodies (which contained a high proportion of
undifferentiated ECCs) from an ascites tumour and transplanted
single cells intraperitoneally, successfully generating clonal tumor-
igenic ECC lines [32]. The ability of these clonal tumours to
differentiate into many different tissue types formally demonstrat-
ed the multipotentiality of the ECCs. This data was complemented
by the demonstration that teratocarcinoma cells cultured on
irradiated feeder cells could also be cloned in vitro and that these
clones were also mulipotential [33]. Martin and Evans charac-
terised in detail the in vitro culture and differentiation of ECCs
[25,26,34]. They demonstrated that undifferentiated ECCs
maintained on a mitotically inactivated feeder cell layer (later
recognized as a source of the differentiation inhibiting factor,
LIF[35]) would form embryoid bodies when cultured for a few
days in suspension in serum containing medium, and that allowing
the cystic embryoid bodies to reattach to the tissue culture dish
triggered further differentiation to many different tissue types, an
observation confirmed by others [25,34,36]. These scientists
recorded two key observations that have been borne out over
subsequent decades. Firstly, they observed that tissues formed from
ECCs differentiated in vitro retained a degree of structural
organisation reminiscent of normal embryonic development, and
secondly they noted ‘‘that the processes of cell determination and
differentiation occur in defined stages which are accessible to
experimental analysis and manipulation.’’ [25,34]. Indeed, Strick-
land and Mahdavi later showed that retinoic acid induced parietal
endoderm differentiation from F9 ECCs [37].
The link between normal embryos and teratocarcinomas had
been made when Solter [38] and Stevens [39] showed that
transplantation of early mouse embryos to an extrauterine site led
to the development of transplantable teratocarcinomas. The
eventual derivation of ESCs, which phenotypically resembled
ECCs, from preimplantation mouse blastocysts in 1981 indepen-
dently by Evans and Martin [40,41] shifted interest away from
teratocarcinomas and ECCs and marked the beginning of the next
era in pluripotent cell research, which has gained further
momentum following the derivation of human embryonic stem
cell lines in 1998 [42,43] and the reprogramming of somatic cells
to a pluripotent state reported in 2006 [44].
We have built on these earlier observations though our
investigations of the induction of mesendoderm precursors by
exogenously acting growth factors in differentiating mouse ESCs.
Whilst early studies proved that ECCs (and later ESCs) could
differentiate to form derivatives of the germ layers, the signals
initiating differentiation were provided by serum and a specific
dissection of the control mechanisms was not possible. We have
used a suspension, embryoid body differentiation system, in which
a serum free defined medium enabled us to objectively assess the
influence of specific growth factors. Our studies were also aided by
the use of a genetically modified ES cell line in which the induction
of Mixl1, a homeobox gene that marks the primitive streak of the
mammalian embryo, was linked to a fluorescent reporter
[17,21,45]. Whilst numerous recent studies prior to ours have
identified factors that induce and pattern mesoderm and
endoderm (reviewed in [46]), we have defined temporal limits
that constrain this process. We have shown that ESCs pass
through a series of ‘windows’ in which they gain and lose
competence to respond to three inducers of primitive streak
transcription factors, BMP4, Wnt3a and Activin A. Through a
series of mixing experiments, we demonstrated that endogenously
Figure 6. Wnt3a and Activin A synergise to induce GFP in
Mixl1
GFP/w EBs. (A) Flow cytometry analysis at d5 of a representative
experiment of Mixl1
GFP/w ESCs differentiated in cultures supplemented
with 100 ng/ml Wnt3a (W) and/or 100 ng/ml Activin A (A) from the
time indicated. The no growth factor (-GF) control is shown to the left.
(B) Histogram summarising the d5 flow cytometry data from Mixl1
GFP/w
ESCs differentiated in cultures supplemented with the indicated growth
factors from the time indicated. (mean6sd, n=3)( *p ,0.05 compared
to d3A). B; BMP4, W; Wnt3a, A; Activin A.
doi:10.1371/journal.pone.0010706.g006
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BMP4 and Wnt3a could propagate mesendoderm signals in
differentiating EBs in a paracrine manner. Finally, we showed that
a portion of the differentiating cells were committed to
mesendoderm formation by d3 and did not require further
signalling from inducing molecules during the last 2 days of
differentiation for Mixl1 expression.
Following the removal of the anti-differentiative signal, LIF,
cells gained responsiveness to BMP4 and Wnt3a as mesendoderm
inducing signals between d1.5 and d3, at a time corresponding to
their upregulation of epiblast associated genes, such as FGF5 [2].
This epiblast stage in ES cells, recently characterised by the
(reversible) transition of cells from a Rex1
+Oct4
+ ESC phenotype
to a Rex1
-Oct4
+ epiblast-like state [47], may be analogous to
embryo derived pluripotent epiblast stem cells that are dependent
on Activin and FGF signalling [48]. In this regard, our
observations that Activin A treatment from day 0 to d2 maintained
high levels of E-Cadherin and did not induce substantial GFP
expression from Mixl1
GFP/w cells (data not shown), were consistent
with the hypothesized anti-differentiative role for nodal (which
signals via the Activin receptor) during the earliest stages of
differentiation [48–50]. Consistent with the hypothesis that the
epiblast state correlates with BMP4 responsiveness, recent data
demonstrates that differentiation of primordial germ cells from
epiblast stem cells is a BMP4-dependent process [51].
From d3 of mESC differentiation, the window of competence
began to close with cells no longer responding to BMP4 and Wnt
signals alone, although cells remained Activin A responsive for a
further day. This extended temporal window for mesendoderm
induction by Activin A may reflect the prolonged role of nodal in
maintaining the anterior streak at the latter stages of gastrulation
[52,53]. In fact, gene expression analysis indicated that whilst both
BMP4 and Wnt3a robustly induced the pan-mesendoderm
markers Brachyury and Mixl1 at d3, they only weakly up-regulated
the anterior mesendoderm/early endoderm markers Goosecoid,
Foxa2, and Sox17. Conversely, Activin A induced higher levels of
these genes at d5 of differentiation (Figure 5 and Figure S2). These
data are in accordance with the results reported by others that
BMP4 and Wnt3a signals induced predominantly a posterior
primitive streak mesoderm in differentiating ESCs whilst Activin A
biased differentiation towards anterior primitive streak derivatives
including definitive endoderm [16,18–20,54].
Our experiments illustrate the integration of signalling pathways
required for induction of Mixl1 (summarised in Figure 7A). In
BMP4 stimulated cultures, transcription of BMP4, Wnt3, Wnt8a
and nodal were induced and inhibition of either BMP or nodal
signalling pathways eliminated Mixl1GFP expression. The consis-
tent persistence of a residual percentage of Mixl1GFP
+ cells in the
presence of Dkk-1 argued that some BMP4 mediated mesendo-
derm differentiation might be Wnt independent. Induction of
Mixl1GFP
+ cells in Wnt3a or Activin A stimulated cultures was
completely abrogated by inhibitors of either pathway. Treatment
of Wnt3a-stimulated cultures with noggin consistently reduced the
percentage of Mixl1GFP-expressing cells, perhaps suggesting a
functional consequence of the significant level of BMP4 transcrip-
tion induced by Wnt3a. Conversely, treatment with noggin had
little effect on Mixl1GFP induction by Activin A. These in vitro
results contrast with findings in the embryo, in which a block in
Figure 7. Induction of Mixl1 expression is regulated through the integration of signals from BMP, Wnt and Activin/nodal pathways.
(A) Interactions between signalling pathways and inhibitors impacting upon Mixl1 induction. BMP4 stimulates expression of Wnt and Activin/nodal,
which in turn induce Mixl1, perhaps acting through as yet unidentified intermediate molecules. The time periods (in days) and differentiation stages
during which the differentiating ES cells are responsive to each stimulus are indicated. Probable autocrine (A) and paracrine (P) roles of the factors are
indicated. (B) Removal of factors maintaining pluripotency enables ES cells to differentiate and to respond to BMP4, Wnt3a or Activin A signals
delivered during a defined ‘temporal window’ for mesendoderm induction. (C) After cells pass through the mesendoderm window at d3, they then
pass through ‘exit gates’ for each signalling pathway, after which time they are no longer dependent on that pathway for mesendoderm induction. In
response to BMP4 addition between d1.5 and d3, the approximate percentage of cells that have passed the BMP4, Wnt3a or Activin A ‘exit gates’ at
d3 is shown. See text for more details (Data taken from Figure 5B).
doi:10.1371/journal.pone.0010706.g007
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embryo is then unable to produce downstream Wnt and nodal,
a block that can be bypassed through the addition of exogenous
factors in vitro. Our results are also in general agreement with
knockout studies in the mouse [7–11,14] and inhibitor experi-
ments in ESCs [16,18–20] that indicated that Wnt and Activin
signalling were essential for mesendoderm induction.
Our data demonstrating that BMP4 propagates mesendoderm-
inducing signals in differentiating EBs via the induction of
endogenous TGF and Wnt growth factors are also consistent with
the autoregulatory induction loops proposed to initiate and
maintain gastrulation in mouse embryos [55]. In this model,
uncleaved nodal protein first up-regulates expression of BMP4 in
the extraembryonic ectoderm. In turn, extraembryonic BMP4
then signals to the embryo proper to initiate Wnt3 expression in
the posterior visceral endoderm and epiblast. Wnt3 specifies
mesoderm and acts to maintain nodal expression within the epiblast
[55]. We explored this integration of signalling pathways through
mixing experiments which showed that ESCs differentiated in
response to BMP4 or Wnt3a propagated a paracrine GFP-
inducing signal to d3 unstimulated Mixl1
GFP/w EBs. Intriguingly,
the transferred inductive signals were blocked not only by nodal
inhibition, but also by Dkk-1 and partly by noggin, indicating a
requirement for Wnt and BMP4 signalling even after closure of the
window for response to these factors at d3. Studies in which these
factors were added alone and in combination at d3 of
differentiation confirmed our findings that direct BMP4 and
Wnt3a responsiveness were greatly reduced after d3 but
demonstrated that a significant population of cells were still
responsive to Activin A. This observation suggests that nodal is a
strong candidate for the predominant paracrine signalling
molecule. The synergy that we observed between Activin and
Wnt3a has previously been reported in normal mouse develop-
ment [56] and in the context of human cancers [57,58].
Mechanistically, in our experiments the results might reflect
induction of nodal and its co receptor cripto (data not shown), by
Wnt3a and Activin A. This synergy is also consistent with results
reported by Hansson and colleagues who noted the late
requirement for Wnt signalling in Activin A induction of Sox17
+
definitive endoderm [20].
The higher frequency of d5 GFP
+ cells observed in cultures
where growth factors were removed at d3 compared with cultures
that were also treated with inhibitors, suggested that mesendoderm
formation remained dependent upon a growth factor for a short
period even after it was removed from the culture. Experiments in
which we evaluated the effects of adding inhibitors to growth
factor induced cultures after d3 confirmed that the requirement for
BMP4 was lost earlier than dependence upon Wnt or nodal
signalling. This was evidenced by the higher percentages of d5
Mixl1GFP
+ cells in noggin treated cultures compared to cultures
in which Wnt or Activin signalling was inhibited (Figure 5B). In
response to BMP4 stimulation, the frequency of GFP
+ cells in d3
noggin treated cultures was ,80% of the frequency without
inhibitors whilst treatment with Dkk-1 or SB 431542 reduced the
frequency of GFP
+ cells to ,30% and ,20% of this value
respectively. Similarly, in cultures stimulated by Wnt3a or Activin
A, the frequency of GFP
+ cells in d3 noggin treated cultures was
,65% of the frequency without inhibitors whilst the inclusion of
either Dkk-1 or SB 431542 reduced the frequency of GFP
+ cells to
,25% of the untreated value for Wnt stimulated cultures and
,10% of this value for Activin A stimulated cultures. These data
suggested that the wave of prospective mesendoderm passed
through a series of ‘gates’ which marked its ‘exit’ from dependence
on BMP4, Wnt and Activin/nodal signalling (Figure 7B). These
‘exit gates’ corresponded to the point at which addition of
inhibitors no longer diminished the subsequent appearance of
Mixl1GFP
+ cells. As such, the lesser reduction in the percentage of
GFP
+ cells observed at d5 in cultures receiving noggin at d3
compared with cultures receiving Dkk-1 or SB 431542, indicated
that dependence on BMP signalling was lost earlier than the
requirement for Wnt or Activin/nodal signalling.
Overall, this study showed that differentiating mouse ESCs
passed through specific ‘temporal windows’ in which cells gained
and lost responsiveness to particular factors. It also demonstrated
the requirement for an integrated network of signalling
molecules to maintain the process of mesendoderm induction.
Further studies investigating the detailed molecular mechanisms
underpinning these observations will provide additional insights
into the regulation of the germ layers during mammalian
development.
Materials and Methods
ESC growth and differentiation
The Mixl1
w/w (W9.5) [59] and Mixl1
GFP/w (clone Mix147 and
Mix114) [17,22] ESC lines were maintained as described [60].
Differentiation was initiated by allowing EBs to form in cultures of
disaggregated ESCs seeded at 1610
4 cells/ml in non-adherent
6 cm bacteriological dishes (Phoenix Biomedical) or by spin EB
formation with 5610
2 cells seeded per well in non-adherent round
bottomed 96 well plates (Nunc) in a chemically defined medium
(CDM) [17,23] as described [61]. The growth factors BMP4
(10 ng/ml), Activin A (100 ng/ml) (both from R&D Systems) and
Wnt3a (100 ng/ml) (Millipore) were added at the indicated times
in each experiment. The effective concentrations of the nodal
signalling inhibitor, SB 431542 (Sigma Aldrich), the BMP
signalling inhibitor, noggin (R&D Systems) and the Wnt inhibitor,
Dkk-1 (R & D Systems) were determined by titrating each factor
into mESC cultures differentiated in the presence of 100 ng/ml
Activin A, 10 ng/ml BMP4 and 100 ng/ml Wnt3a, respectively.
These experiments showed that 4 mM SB 431542, 100 ng/ml
noggin or 200 ng/ml Dkk-1 was sufficient to block ligand-induced
GFP expression in Mixl1
GFP/w cells. Growth factors were removed
from the cultures by pelleting EBs by centrifugation (4806g),
aspirating the media, washing once with PBS, and resuspending
the EBs in fresh CDM. The EBs were then transferred to a non-
adherent bacteriological dish and returned to a humidified 37uC
incubator (8% CO2 in air). GFP expression was analysed by flow
cytometry at day 5 of differentiation unless otherwise stated.
Differentiation of chimeric embryoid bodies
Mixl1
w/w and Mixl1
GFP/w cells were differentiated as EBs in
parallel cultures for 3d. Mixl1
w/w EBs were differentiated in the
absence of growth factors (control cells) or in the presence of
BMP4 (10 ng/ml), Wnt3a (100 ng/ml) or Activin A (100 ng/ml)
(stimulator cells). BMP4 and Wnt3a were included from the onset
of differentiation whilst Activin A was added at d2. For the first 3d,
Mixl1
GFP/w cells (responder cells) were differentiated in the
absence of added growth factors. After 3d, EBs from both lines
were harvested, washed in PBS, and trypsinised to form a single
cell suspension. The disaggregated Mixl1
w/w and Mixl1
GFP/w cells
were combined at a ratio of 1:1 in CDM. Two thousand cells were
placed into each well of low adherent round bottomed 96 well
trays (Nunc) and chimeric spin EBs were formed by aggregation of
the cells following centrifugation [61]. Inhibitors of signalling were
added as indicated. The differentiation was allowed to proceed
until d5 when the chimeric EBs were disaggregated with trypsin
and the cells were analysed by flow cytometry for GFP expression.
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RNA was extracted using an RNeasy Mini Kit (Qiagen) and
cDNA synthesized using SuperScript III (Invitrogen Corporation)
according to the manufacturer’s instructions. PCR gene expression
analysis was performed as described previously [62]. Samples from
separate experiments involving BMP4, Wnt3a and Activin A
treatments were all standardised against the HPRT expression
from a single RNA sample derived from undifferentiated mESCs.
PCRs were carried out using Platinum Taq DNA Polymerase
High Fidelity (Invitrogen) with the primer pairs and PCR
conditions listed in Table S1. Quantitative real time Taqman
gene expression analysis was performed according to the
manufacturer’s instructions using the probe sets listed in Table
S2 and processed as described [63].
Supporting Information
Figure S1 BMP4, Wnt3a and Activin A display a similar pattern
of mesendoderm inducing activity in differentiating Mixl1GFP/w
clone Mix 114. (A) Flow cytometry analysis of d5 Mixl1GFP/w
clone 114 ESCs differentiated in cultures supplemented with
10ng/ml BMP4, 100ng/ml Wnt3a or 100ng/ml Activin A for the
given time intervals, indicating the proportion of GFP+ cells. The
growth factor treatment for each experiment is indicated and the
corresponding no growth factor (-GF) control flow cytometry
profiles are shown to the left of each series. (B) Representative
brightfield and epifluorescence images of differentiating EBs. The
growth factors and period of addition are indicated to the left of
each row and day of differentiation when the image was taken in
the top right hand corner of each panel. (Original magnification x
100).
Found at: doi:10.1371/journal.pone.0010706.s001 (12.87 MB
TIF)
Figure S2 Kinetics of mesendoderm gene expression in EBs
differentiated in BMP4, Wnt3a and Activin A. Real time PCR
analysis for the indicated genes at (A) d3 and (B) d5 in ESCs
differentiated in the absence of growth factors (-GF) or presence of
BMP4, Wnt3a or Activin A for the indicated periods (mean6sem,
n=3).
Found at: doi:10.1371/journal.pone.0010706.s002 (2.19 MB TIF)
Table S1 Sequences of primers used for PCR analysis shown in
Figure 2 and 5.
Found at: doi:10.1371/journal.pone.0010706.s003 (0.04 MB
DOC)
Table S2 Probe sets for real-time PCR analysis shown in
Figure 3 and Figure S2.
Found at: doi:10.1371/journal.pone.0010706.s004 (0.03 MB
DOC)
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